Among them, the quinoline-derived small molecule HN-N07 inhibited the target genes BIRC5/HIF1A/FLT4, and became a potential inhibitor of the NSCLC cancer-causing signaling pathway [157]. The gene discussed is FLT4; the disease is non-small cell lung carcinoma.